Please login to the form below

Not currently logged in
Email:
Password:

Saizen

This page shows the latest Saizen news and features for those working in and with pharma, biotech and healthcare.

Merck completes €15m Spanish biotech facility expansion

Merck completes €15m Spanish biotech facility expansion

The Tres Cantos plant is Merck's main site for the production of active substances in its fertility treatment Gonal-f and endocrine and metabolic disorders treatment Saizen, for which global

Latest news

  • Sales down at Merck Serono on Rebif pressure Sales down at Merck Serono on Rebif pressure

    Among its other products, sales of Merck Serono's fertility treatment Gonal-f (follitropin alfa) slipped fractionally to 137m while growth hormone Saizen (somatropin) brought in 61m, in line with one

  • Merck KGaA to meet 2014 financial targets one year early Merck KGaA to meet 2014 financial targets one year early

    This performance helped offset declines for other key brands, such as fertility treatment Gonal-f (follitropin alfa) and growth hormone product Saizen (somatropin), down 4 and 8 per cent to 145m

  • Merck Serono to invest €150m in China R&D

    The Swiss-based company's key products Erbitux (cancer), Rebif (multiple sclerosis), Gobal-f (infertility), Saizen (endocrine and metabolic disorders) and Concor and Euthyrox (cardiometabolic diseases) are already available in the

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics